Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.89B |
| 2 |
Tesla
TSLA
|
+$788M |
| 3 |
Broadcom
AVGO
|
+$772M |
| 4 |
Amazon
AMZN
|
+$768M |
| 5 |
Workday
WDAY
|
+$649M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$6.5B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$898M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$565M |
| 4 |
Vanguard FTSE Europe ETF
VGK
|
+$441M |
| 5 |
Palo Alto Networks
PANW
|
+$429M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 4.36% |
| 2 | Consumer Discretionary | 2.24% |
| 3 | Healthcare | 1.2% |
| 4 | Financials | 1.17% |
| 5 | Communication Services | 1.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4701
CALL
Veralto
VLTO
$23.9B
| $1.57M | ﹤0.01% |
+19,108
| New | +$1.43M |
|
4702
CALL
Appian
APPN
$2.54B
| $1.57M | ﹤0.01% |
41,600
+14,900
| +56% | +$582K |
|
|
CGC
4703
Canopy Growth
CGC
$422M
| $1.57M | ﹤0.01% |
307,130
+115,557
| +60% | +$688K |
|
4704
Medifast
MED
$130M
| $1.56M | ﹤0.01% |
23,264
-17,529
| -43% | -$1.22M |
|
4705
PUT
Verra Mobility
VRRM
$726M
| $1.56M | ﹤0.01% |
67,800
+52,800
| +352% | +$1.08M |
|
4706
CALL
Mid-America Apartment Communities
MAA
$15.3B
| $1.56M | ﹤0.01% |
11,600
+9,100
| +364% | +$1.16M |
|
4707
PUT
Doximity
DOCS
$4.65B
| $1.56M | ﹤0.01% |
55,500
+12,000
| +28% | +$283K |
|
4708
Greif
GEF
$4.98B
| $1.56M | ﹤0.01% |
23,712
+1,557
| +7% | +$103K |
|
|
CPRX
4709
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.55M | ﹤0.01% |
92,482
-84,835
| -48% | -$1.16M |
|
4710
First Trust STOXX European Select Dividend Income Fund
FDD
$906M
| $1.55M | ﹤0.01% |
128,777
-447,904
| -78% | -$4.99M |
|
4711
UPAR Ultra Risk Parity ETF
UPAR
$58.7M
| $1.55M | ﹤0.01% |
113,725
+22,317
| +24% | +$277K |
|
|
LAR
4712
Lithium Argentina AG
LAR
$1.09B
| $1.55M | ﹤0.01% |
+245,606
| New | +$1.48M |
|
|
AVDL
4713
DELISTED
Avadel Pharmaceuticals
AVDL
| $1.55M | ﹤0.01% |
109,905
+88,225
| +407% | +$1.04M |
|
4714
First Trust Eurozone AlphaDEX
FEUZ
$133M
| $1.55M | ﹤0.01% |
38,171
+23,093
| +153% | +$873K |
|
4715
Simplify Multi-QIS Alternative ETF
QIS
$39.8M
| $1.55M | ﹤0.01% |
62,746
+41,166
| +191% | +$1.05M |
|
4716
PUT
Elanco Animal Health
ELAN
$11.4B
| $1.55M | ﹤0.01% |
103,900
+54,800
| +112% | +$621K |
|
4717
KraneShares Bosera MSCI China A 50 Connect Index ETF
KBA
$147M
| $1.55M | ﹤0.01% |
74,731
-249,244
| -77% | -$5.33M |
|
4718
CALL
DoubleVerify
DV
$2.03B
| $1.54M | ﹤0.01% |
42,000
-27,400
| -39% | -$854K |
|
4719
Digital Turbine
APPS
$1.58B
| $1.54M | ﹤0.01% |
224,937
+66,492
| +42% | +$371K |
|
4720
Churchill Downs
CHDN
$6.18B
| $1.54M | ﹤0.01% |
11,410
-6,539
| -36% | -$776K |
|
4721
MannKind Corp
MNKD
$1.23B
| $1.53M | ﹤0.01% |
421,600
+142,827
| +51% | +$546K |
|
4722
CALL
UBS Group
UBS
$176B
| $1.53M | ﹤0.01% |
49,660
-16,260
| -25% | -$428K |
|
|
FLNA
4723
PUT
Filana Therapeutics
FLNA
$46.9M
| $1.53M | ﹤0.01% |
66,800
-106,900
| -62% | -$2.26M |
|
4724
Encompass Health
EHC
$12.4B
| $1.53M | ﹤0.01% |
22,960
-41,551
| -64% | -$2.69M |
|
|
PR
4725
PUT
Permian Resources
PR
$18B
| $1.53M | ﹤0.01% |
112,572
+86,572
| +333% | +$1.19M |
|
Similar funds
Jane Street's Q4 2023 Portfolio in Review
As of Q4 2023, Jane Street held 10,187 positions worth $384B, up 24% from $309B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
Jane Street deployed $33.7B of net new capital in Q4 2023, opening 1,659 new positions and adding to 4,053 existing holdings. Its largest new stake was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
By sector, the portfolio is most concentrated in Technology at 4.4% of assets, up from 2.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $6.5B trimmed.
- Jane Street's largest Q4 2023 buy was Schwab Fundamental International Large Company Index ETF: 10,652,718 shares worth $359M.
- Jane Street added most to Microsoft in Q4 2023, an estimated $1.89B increase.
- Jane Street's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $6.5B.
- Jane Street fully exited JPMorgan USD Emerging Markets Sovereign Bond ETF in Q4 2023, selling an estimated $121M.
- Jane Street's ten largest holdings make up 38% of its $384B portfolio in Q4 2023.
- Jane Street opened 1,659 new positions and closed 1,080 in Q4 2023.
- Jane Street's portfolio value rose 24% quarter-over-quarter to $384B.
Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.